We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Impax, AstraZeneca Get Win In Generic Zomig Patent Case

Law360, New York (April 3, 2017, 5:32 PM EDT) -- A Delaware federal judge has given a victory to Impax Laboratories Inc. and AstraZeneca AB in their patent infringement suit over Lannett Holdings Inc.’s planned generic version of the migraine medication...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.